90 related articles for article (PubMed ID: 27428649)
1. Development of anti-HIV peptides based on a viral capsid protein.
Mizuguchi T; Ohashi N; Matsumoto D; Hashimoto C; Nomura W; Yamamoto N; Murakami T; Tamamura H
Biopolymers; 2017 Jan; 108(1):. PubMed ID: 27428649
[TBL] [Abstract][Full Text] [Related]
2. Anti-HIV screening for cell-penetrating peptides using chloroquine and identification of anti-HIV peptides derived from matrix proteins.
Mizuguchi T; Ohashi N; Nomura W; Komoriya M; Hashimoto C; Yamamoto N; Murakami T; Tamamura H
Bioorg Med Chem; 2015 Aug; 23(15):4423-4427. PubMed ID: 26094944
[TBL] [Abstract][Full Text] [Related]
3. Conjugation of cell-penetrating peptides leads to identification of anti-HIV peptides from matrix proteins.
Narumi T; Komoriya M; Hashimoto C; Wu H; Nomura W; Suzuki S; Tanaka T; Chiba J; Yamamoto N; Murakami T; Tamamura H
Bioorg Med Chem; 2012 Feb; 20(4):1468-74. PubMed ID: 22277590
[TBL] [Abstract][Full Text] [Related]
4. Potent leads based on CA-19L, an anti-HIV active HIV-1 capsid fragment.
Tsuji K; Wang R; Kobayakawa T; Owusu KB; Fujino M; Kaneko M; Yamamoto N; Murakami T; Tamamura H
Bioorg Med Chem; 2021 Jan; 30():115923. PubMed ID: 33316719
[TBL] [Abstract][Full Text] [Related]
5. Exploratory studies on CA-15L, an anti-HIV active HIV-1 capsid fragment.
Tsuji K; Owusu KB; Kobayakawa T; Wang R; Fujino M; Kaneko M; Yamamoto N; Murakami T; Tamamura H
Bioorg Med Chem; 2020 Jun; 28(11):115488. PubMed ID: 32305183
[TBL] [Abstract][Full Text] [Related]
6. Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.
Bocanegra R; Nevot M; Doménech R; López I; Abián O; Rodríguez-Huete A; Cavasotto CN; Velázquez-Campoy A; Gómez J; Martínez MÁ; Neira JL; Mateu MG
PLoS One; 2011; 6(9):e23877. PubMed ID: 21931621
[TBL] [Abstract][Full Text] [Related]
7. Anti-HIV-1 peptide derivatives based on the HIV-1 Co-receptor CXCR4.
Hashimoto C; Nomura W; Narumi T; Fujino M; Tsutsumi H; Haseyama M; Yamamoto N; Murakami T; Tamamura H
ChemMedChem; 2013 Oct; 8(10):1668-72. PubMed ID: 24039179
[TBL] [Abstract][Full Text] [Related]
8. α-Aminoisobutyric acid incorporation induces cell permeability and antiviral activity of HIV-1 major homology region fragments.
Lampel A; Elis E; Guterman T; Shapira S; Marco P; Bacharach E; Gazit E
Chem Commun (Camb); 2015 Aug; 51(62):12349-52. PubMed ID: 26121332
[TBL] [Abstract][Full Text] [Related]
9. Small-Molecule Anti-HIV-1 Agents Based on HIV-1 Capsid Proteins.
Kobayakawa T; Yokoyama M; Tsuji K; Fujino M; Kurakami M; Boku S; Nakayama M; Kaneko M; Ohashi N; Kotani O; Murakami T; Sato H; Tamamura H
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33546092
[TBL] [Abstract][Full Text] [Related]
10. Specific Inhibitors of HIV Capsid Assembly Binding to the C-Terminal Domain of the Capsid Protein: Evaluation of 2-Arylquinazolines as Potential Antiviral Compounds.
Machara A; Lux V; Kožíšek M; Grantz Šašková K; Štěpánek O; Kotora M; Parkan K; Pávová M; Glass B; Sehr P; Lewis J; Müller B; Kräusslich HG; Konvalinka J
J Med Chem; 2016 Jan; 59(2):545-58. PubMed ID: 26685880
[TBL] [Abstract][Full Text] [Related]
11. The HIV-1 capsid protein as a drug target: recent advances and future prospects.
Domenech R; Neira JL
Curr Protein Pept Sci; 2013 Dec; 14(8):658-68. PubMed ID: 24106962
[TBL] [Abstract][Full Text] [Related]
12. Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication.
Thenin-Houssier S; de Vera IM; Pedro-Rosa L; Brady A; Richard A; Konnick B; Opp S; Buffone C; Fuhrmann J; Kota S; Billack B; Pietka-Ottlik M; Tellinghuisen T; Choe H; Spicer T; Scampavia L; Diaz-Griffero F; Kojetin DJ; Valente ST
Antimicrob Agents Chemother; 2016 Apr; 60(4):2195-208. PubMed ID: 26810656
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships (SAR) research of thiourea derivatives as dual inhibitors targeting both HIV-1 capsid and human cyclophilin A.
Chen K; Tan Z; He M; Li J; Tang S; Hewlett I; Yu F; Jin Y; Yang M
Chem Biol Drug Des; 2010 Jul; 76(1):25-33. PubMed ID: 20456372
[TBL] [Abstract][Full Text] [Related]
14. The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly.
Neira JL
FEBS J; 2009 Nov; 276(21):6110-7. PubMed ID: 19825045
[TBL] [Abstract][Full Text] [Related]
15. Peptide triazole inactivators of HIV-1: how do they work and what is their potential?
Chaiken I; Rashad AA
Future Med Chem; 2015; 7(17):2305-10. PubMed ID: 26599515
[No Abstract] [Full Text] [Related]
16. Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: structure-activity relationships (SAR) of the C3-phenyl moiety.
Fader LD; Landry S; Goulet S; Morin S; Kawai SH; Bousquet Y; Dion I; Hucke O; Goudreau N; Lemke CT; Rancourt J; Bonneau P; Titolo S; Amad M; Garneau M; Duan J; Mason S; Simoneau B
Bioorg Med Chem Lett; 2013 Jun; 23(11):3401-5. PubMed ID: 23601710
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of anti-HIV-1 peptides with disulfide linkage between D- and L-cysteine at positions i and i+3, respectively, derived from HIV-1 gp41 C-peptide.
Lee MK; Kim HK; Lee TY; Hahm KS; Kim KL
Exp Mol Med; 2006 Feb; 38(1):18-26. PubMed ID: 16520549
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiviral activities of novel acylhydrazone derivatives targeting HIV-1 capsid protein.
Tian B; He M; Tang S; Hewlett I; Tan Z; Li J; Jin Y; Yang M
Bioorg Med Chem Lett; 2009 Apr; 19(8):2162-7. PubMed ID: 19297155
[TBL] [Abstract][Full Text] [Related]
19. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.
Li J; Tan Z; Tang S; Hewlett I; Pang R; He M; He S; Tian B; Chen K; Yang M
Bioorg Med Chem; 2009 Apr; 17(8):3177-88. PubMed ID: 19328002
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of highly potent small molecule-peptide conjugates as new HIV-1 fusion inhibitors.
Wang C; Shi W; Cai L; Lu L; Wang Q; Zhang T; Li J; Zhang Z; Wang K; Xu L; Jiang X; Jiang S; Liu K
J Med Chem; 2013 Mar; 56(6):2527-39. PubMed ID: 23458727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
